Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid. [electronic resource]
Producer: 20090309Description: 208-14 p. digitalISSN:- 1940-6215
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bexarotene
- Carcinoma -- genetics
- Celecoxib
- Cell Transformation, Neoplastic -- drug effects
- Chemoprevention -- methods
- Cyclooxygenase 2 Inhibitors -- administration & dosage
- Drug Evaluation, Preclinical
- Eicosanoids -- metabolism
- Female
- Genes, erbB-2 -- physiology
- Mammary Neoplasms, Experimental -- genetics
- Mammary Tumor Virus, Mouse -- genetics
- Mice
- Mice, Transgenic
- Pyrazoles -- administration & dosage
- Retinoid X Receptors -- agonists
- Retinoids -- administration & dosage
- Substrate Specificity -- drug effects
- Sulfonamides -- administration & dosage
- Tetrahydronaphthalenes -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.